Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer After Subcapsular Renal Hematoma

Q4 Medicine
Kazuma Soya, Takeru Fujimoto, Daisuke Takahashi, Kana Kohashiguchi, Yusuke Takei, Yoshio Sugino, Hiroshi Iwamura
{"title":"Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer After Subcapsular Renal Hematoma","authors":"Kazuma Soya,&nbsp;Takeru Fujimoto,&nbsp;Daisuke Takahashi,&nbsp;Kana Kohashiguchi,&nbsp;Yusuke Takei,&nbsp;Yoshio Sugino,&nbsp;Hiroshi Iwamura","doi":"10.1002/iju5.70009","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare autosomal dominant genetic disorder. We report a case diagnosed with HLRCC following a subcapsular renal hematoma caused by a tumor.</p>\n </section>\n \n <section>\n \n <h3> Case Presentation</h3>\n \n <p>A 28-year-old woman with a history of uterine myomas presented with left back pain. Computed tomography revealed a renal mass with a subcapsular hematoma, and coil embolization was performed. The tumor had enlarged rapidly, and <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography revealed significant <sup>18</sup>F-fluorodeoxyglucose uptake, suggesting malignancy. Subsequently, robot-assisted radical nephrectomy was performed. Histopathological examination confirmed papillary renal carcinoma (Stage pT2aN0M0). Fumarate hydratase immunostaining was negative, and a fumarate hydratase gene pathogenic germline variant confirmed the HLRCC diagnosis. No recurrence has been reported for 2 years since the surgery.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>A combination of imaging tests using multiple modalities and close follow-ups contributed to establishing an accurate diagnosis and providing early definitive treatment.</p>\n </section>\n </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 3","pages":"218-222"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70009","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJU Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/iju5.70009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare autosomal dominant genetic disorder. We report a case diagnosed with HLRCC following a subcapsular renal hematoma caused by a tumor.

Case Presentation

A 28-year-old woman with a history of uterine myomas presented with left back pain. Computed tomography revealed a renal mass with a subcapsular hematoma, and coil embolization was performed. The tumor had enlarged rapidly, and 18F-fluorodeoxyglucose positron emission tomography/computed tomography revealed significant 18F-fluorodeoxyglucose uptake, suggesting malignancy. Subsequently, robot-assisted radical nephrectomy was performed. Histopathological examination confirmed papillary renal carcinoma (Stage pT2aN0M0). Fumarate hydratase immunostaining was negative, and a fumarate hydratase gene pathogenic germline variant confirmed the HLRCC diagnosis. No recurrence has been reported for 2 years since the surgery.

Conclusion

A combination of imaging tests using multiple modalities and close follow-ups contributed to establishing an accurate diagnosis and providing early definitive treatment.

Abstract Image

肾包膜下血肿后遗传性平滑肌瘤病和肾细胞癌的诊断
遗传性平滑肌瘤病合并肾细胞癌(HLRCC)是一种罕见的常染色体显性遗传病。我们报告一个病例诊断为肾小细胞癌后的包膜下血肿引起的肿瘤。病例介绍一名28岁女性,有子宫肌瘤病史,表现为左背部疼痛。计算机断层扫描显示肾肿块伴包膜下血肿,行线圈栓塞术。肿瘤迅速增大,18f -氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描显示明显的18f -氟脱氧葡萄糖摄取,提示恶性肿瘤。随后进行机器人辅助根治性肾切除术。组织病理学检查证实乳头状肾癌(pT2aN0M0期)。富马酸水合酶免疫染色为阴性,富马酸水合酶基因致病种系变异证实了HLRCC的诊断。术后2年无复发报告。结论结合多种方式的影像学检查和密切随访有助于建立准确的诊断和提供早期明确的治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
IJU Case Reports
IJU Case Reports Medicine-Urology
CiteScore
0.60
自引率
0.00%
发文量
147
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信